180 related articles for article (PubMed ID: 2332245)
1. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
Heizmann WR; Heilmann F; Egeler B; Werner H
Infection; 1990; 18(2):117-21. PubMed ID: 2332245
[TBL] [Abstract][Full Text] [Related]
2. Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.
Heizmann WR; Schmid R; Heilmann F; Werner H
Infection; 1989; 17(3):160-4. PubMed ID: 2737759
[TBL] [Abstract][Full Text] [Related]
3. Ampicillin and ampicillin-sulbactam dilution tests with mixed cultures of Bacteroides fragilis, Escherichia coli and Enterococcus.
Heilmann F
Infection; 1993; 21(3):187-90. PubMed ID: 8365818
[TBL] [Abstract][Full Text] [Related]
4. A multicenter international study on the activity of sulbactam/ampicillin, ampicillin, and cefoxitin against anaerobic bacteria and introduction of a new model of susceptibility testing in mixed infections.
Heizmann WR; Heilmann F; Werner H
Suppl Int J Gynecol Obstet; 1989; 2():7-12; discussion 47-8. PubMed ID: 2679683
[TBL] [Abstract][Full Text] [Related]
5. Patterns of resistance to anaerobic organisms in Australia.
Munro R
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):159S-163S. PubMed ID: 2591175
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
Schumacher U; Manncke B; Gerbracht K; Werner H
Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
[TBL] [Abstract][Full Text] [Related]
7. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.
Leone F; Morandotti MG; Mazzella P; Sanna A; Ravizzola G; Colombrita D; Pinzi G; Turano R; Menozzi MG; Lecchini R
J Int Med Res; 1990; 18(3):191-200. PubMed ID: 2193834
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.
Heizmann W; Heilmann F; Werner H
Infection; 1987; 15(5):370-4. PubMed ID: 3692611
[TBL] [Abstract][Full Text] [Related]
10. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of the sulbactam-ampicillin combination.
Sessarego FV; Botta GA; Pesce A; Schito GC
J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
[TBL] [Abstract][Full Text] [Related]
12. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Rezvan SP; Sidorenko SV; Budanov SV
Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
[TBL] [Abstract][Full Text] [Related]
13. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
Werner H; Heizmann W; Heilmann F
Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
[TBL] [Abstract][Full Text] [Related]
14. Bacteriology of 100 consecutive diabetic foot infections and in vitro susceptibility to ampicillin/sulbactam versus cefoxitin.
Borrero E; Rossini M
Angiology; 1992 Apr; 43(4):357-61. PubMed ID: 1558322
[TBL] [Abstract][Full Text] [Related]
15. Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
Citron DM; Goldstein EJ; Kenner MA; Burnham LB; Inderlied CB
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S356-60. PubMed ID: 7548597
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
[TBL] [Abstract][Full Text] [Related]
17. Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease.
Sweet RL; Landers DV; Schachter J; Crombleholme WR
Suppl Int J Gynecol Obstet; 1989; 2():13-9; discussion 47-8. PubMed ID: 2803578
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice.
Brook I
J Antimicrob Chemother; 1994 Nov; 34(5):791-6. PubMed ID: 7706175
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]